Molecular markers and targeted therapy of skin rejection in composite tissue allotransplantation

American Journal of Transplantation

Volumn 10, Issue 5, 2010, Pages 1200-1209

  Hautz, T ^a   Zelger, B ^b   Grahammer, J ^a   Krapf, C ^a   Amberger, A ^c   Brandacher, G ^a   Landin, L ^d   Muller H ^c   Schon M P ^e   Cavadas, P ^d   Lee, A W P ^f   Pratschke, J ^a   Margreiter, R ^a   Schneeberger, S ^a,b,f  

^a Department of Visceral Transplant and Thoracic Surgery   (United States)

^b Department of Pathology ^*  (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Adhesion molecules; Composite tissue allograft; Composite tissue transplantation; Hand transplantation; Lymphocyte trafficking; Rat; Rejection; Selectin ligand inhibition; Skin; Topical therapy

Indexed keywords

CD68 ANTIGEN; CELL ADHESION MOLECULE; EFOMYCINE M; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOMODULATING AGENT; INDOLEAMINE 2,3 DIOXYGENASE; INTERCELLULAR ADHESION MOLECULE 1; MOLECULAR MARKER; PADGEM PROTEIN; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; COMPOSITE GRAFT; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HAND SURGERY; HAND TRANSPLANTATION; HINDLIMB; HUMAN; HUMAN TISSUE; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKIN BIOPSY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTILYMPHOCYTE SERUM; BIOLOGICAL MARKERS; BIOPSY; E-SELECTIN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTES; MALE; P-SELECTIN; RATS; RATS, INBRED BN; RATS, INBRED LEW; SKIN; TACROLIMUS; TIME FACTORS;

EID: 77951227495     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03075.x     Document Type: Article

References (31)

1. Petruzzo P, Lanzetta M, Dubernard JM et al. The international registry on hand and composite tissue transplantation. Transplantation 2008 86 : 487 492.
2. Ravindra KV, Buell JF, Kaufman CL et al. Hand transplantation in the United States: Experience with 3 patients. Surgery 2008 144 : 638 643 discussion 643 634.
3. Schneeberger S, Gorantla VS, van Riet RP et al. Atypical acute rejection after hand transplantation. Am J Transplant 2008 8 : 688 696. (Pubitemid 351287537)
4. Schneeberger S, Ninkovic M, Gabl M et al. First forearm transplantation: Outcome at 3 years. Am J Transplant 2007 7 : 1753 1762. (Pubitemid 46905428)
5. Schneeberger S, Ninkovic M, Piza-Katzer H et al. Status 5 years after bilateral hand transplantation. Am J Transplant 2006 6 : 834 841. (Pubitemid 43345022)
6. Gazarian A, Abrahamyan DO, Petruzzo P et al. Hand allografts: Experience from Lyon team. Ann Chir Plast Esthet 2007 52 : 424 435.
7. Schneeberger S, Kreczy A, Brandacher G, Steurer W, Margreiter R. Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath-1H. Am J Transplant 2004 4 : 1372 1374. (Pubitemid 39013588)
8. Hettiaratchy S, Melendy E, Randolph MA et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004 77 : 514 521. (Pubitemid 38282804)
9. Mathes DW, Randolph MA, Solari MG et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003 75 : 25 31.
10. Tung TH, Mackinnon SE, Mohanakumar T. Combined treatment with CD40 costimulation blockade, T-cell depletion, low-dose irradiation, and donor bone marrow transfusion in limb allograft survival. Ann Plast Surg 2005 55 : 512 518. (Pubitemid 41552088)
11. Landin L, Cavadas PC, Ibanez J, Roger I, Vera-Sempere F. CD3+-mediated rejection and C4d deposition in two composite tissue (bilateral hand) allograft recipients after induction with alemtuzumab. Transplantation 2009 87 : 776 781.
12. Cavadas PC, Landin L, Ibañez J. Bilateral hand transplantation: Result at 20 months. J Hand Surg Eur Vol 2009 34 : 434 443.
13. Cendales L, Kanitakis J, Schneeberger S et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008 8 : 1396 1400. (Pubitemid 351989486)
14. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003 339 : 62 66. (Pubitemid 36263221)
15. Schön MP, Krahn T, Schön M et al. Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med 2002 8 : 366 372. (Pubitemid 34407031)
16. Wienrich BG, Krahn T, Schön M et al. Structure-function relation of efomycines, a family of small-molecule inhibitors of selectin functions. J Invest Dermatol 2006 126 : 882 889.
17. Hautz T, Brandacher G, Zelger B et al. Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts. Transplant Proc 2009 41 : 509 512.
18. Kanitakis J. The challenge of dermatopathological diagnosis of composite tissue allograft rejection: A review. J Cutan Pathol 2008 35 : 738 744.
19. Kanitakis J, Badet L, Petruzzo P et al. Clinicopathologic monitoring of the skin and oral mucosa of the first human face allograft: Report on the first eight months. Transplantation 2006 82 : 1610 1615. (Pubitemid 46035637)
20. Cendales L, Kirk A, Moresi J, Ruiz P, Kleiner D. Composite tissue allotransplantation: Classification of clinical acute skin rejection. Transplantation 2006 81 : 418 422. (Pubitemid 43255728)
21. Kanitakis J, McGregor B, Badet L et al. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: An immunoperoxidase study. Transplantation 2007 84 : 265 267. (Pubitemid 47205762)
22. Barker JN. Adhesion molecules in cutaneous inflammation. Ciba Found Symp 1995 189 : 91 101 discussion 101 106.
23. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999 341 : 1817 1828.
24. Smith CH, Barker JN. Cell trafficking and role of adhesion molecules in psoriasis. Clin Dermatol 1995 13 : 151 160.
25. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003 112 : S128 S139. (Pubitemid 37550029)
26. Schön MP, Ludwig RJ. Lymphocyte trafficking to inflamed skin-molecular mechanisms and implications for therapeutic target molecules. Expert Opin Ther Targets 2005 9 : 225 243.
27. Lebwohl M, Tyring SK, Hamilton TK et al. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med 2003 349 : 2004 2013. (Pubitemid 37448923)
28. Vincenti F, Mendez R, Pescovitz M et al. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant 2007 7 : 1770 1777. (Pubitemid 46905435)
29. Hirata T, Furie BC, Furie B. P-, E-, and L-selectin mediate migration of activated CD8+ T lymphocytes into inflamed skin. J Immunol 2002 169 : 4307 4313. (Pubitemid 35178203)
30. Staite ND, Justen JM, Sly LM, Beaudet AL, Bullard DC. Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin. Blood 1996 88 : 2973 2979. (Pubitemid 26357378)
31. Zollner TM, Asadullah K, Schön MP. Targeting leukocyte trafficking to inflamed skin: Still an attractive therapeutic approach? Exp Dermatol 2007 16 : 1 12. (Pubitemid 44890345)